Monthly Prescribing Reference: Atrial Fibrillation Risk Increases With Advanced CKM Syndrome Stages A study was conducted to determine the incidence of atrial fibrillation across CKM syndrome stages. MPR, a trusted source of medical news and feature content for healthcare providers, offers ... The New England Journal of Medicine: Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding.

Understanding the Context

Left atrial appendage closure is considered for patients who are ... Medscape: Atrial Fibrillation in Chronic Aortic Regurgitation Linked to Increased Mortality Risk Atrial fibrillation (AF) was present in 1 in 6 patients with chronic aortic regurgitation — either moderate-to-severe or severe — and was independently associated with an increased risk for mortality ... The American Journal of Managed Care: Unmet Needs in the Management of Atrial Fibrillation Experts discuss the persistent clinical and systemic challenges in diagnosing and treating atrial fibrillation, emphasizing the need for earlier identification—especially in high-risk, comorbid ... The New England Journal of Medicine: Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation In a randomized trial involving patients with advanced heart failure and atrial fibrillation, catheter ablation decreased the risk of cardiovascular events at a median of 18 months.

Key Insights

The Conversation: What is atrial fibrillation, the heart condition US President Joe Biden lives with? US President Joe Biden has the heart condition atrial fibrillation. This increases his risk of having a stroke five-fold and doubles the risk of a heart attack or dementia. More than 37.5 million ... What is atrial fibrillation, the heart condition US President Joe Biden lives with?

Final Thoughts

CBS News: Results from University of Miami study could one day change how people with atrial fibrillation are treated Miller School of Medicine could one day change the way people with atrial fibrillation are treated. Researchers at UM conducted the Liraglutide Effects in Atrial Fibrillation (LEAF) study starting in ... Results from University of Miami study could one day change how people with atrial fibrillation are treated